1. Metabolic Enzyme/Protease Anti-infection Autophagy Apoptosis
  2. Aldose Reductase Influenza Virus Autophagy Apoptosis
  3. Isoliquiritigenin

Isoliquiritigenin  (Synonyms: GU17; ISL; Isoliquiritigen; SJ000286237)

Cat. No.: HY-N0102 Purity: 98.02%
COA Handling Instructions

Isoliquiritigenin is an anti-tumor flavonoid from the root of Glycyrrhiza uralensis Fisch., which inhibits aldose reductase with an IC50 of 320 nM. Isoliquiritigenin is a potent inhibitor of influenza virus replication with an EC50 of 24.7 μM.

For research use only. We do not sell to patients.

Isoliquiritigenin Chemical Structure

Isoliquiritigenin Chemical Structure

CAS No. : 961-29-5

Size Price Stock Quantity
Free Sample (0.1 - 0.5 mg)   Apply Now  
Solid + Solvent
10 mM * 1 mL in DMSO
ready for reconstitution
USD 61 In-stock
Solution
10 mM * 1 mL in DMSO USD 61 In-stock
Solid
5 mg USD 35 In-stock
10 mg USD 55 In-stock
50 mg USD 77 In-stock
100 mg USD 105 In-stock
200 mg USD 149 In-stock
500 mg   Get quote  
1 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 21 publication(s) in Google Scholar

Top Publications Citing Use of Products

    Isoliquiritigenin purchased from MedChemExpress. Usage Cited in: Onco Targets Ther. 2018 Mar 22;11:1633-1642.  [Abstract]

    Isoliquiritigenin (ILQ) treatment affects the expression level of apoptosis-related proteins.

    Isoliquiritigenin purchased from MedChemExpress. Usage Cited in: Chemotherapy. 2018 Jun 22;63(3):155-161.  [Abstract]

    Western blot analysis of the effect on Bcl2, Bax, and active Caspase-3 protein expression in Isoliquiritigenin (ISL) treated U2OS cells.

    Isoliquiritigenin purchased from MedChemExpress. Usage Cited in: Oncol Lett. 2018 Nov;16(5):6133-6139.  [Abstract]

    Western blot analysis of the expression of E cadherin, N cadherin and vimentin in A549 cells following treatment with Isoliquiritigenin (ISL) for 48 h.

    Isoliquiritigenin purchased from MedChemExpress. Usage Cited in: Am J Transl Res. 2018 Dec 15;10(12):4141-4151.  [Abstract]

    ISL inhibits phosphorylation of IκB-α following LPS stimulation. The expressions of IκB-α and p-IκB are measured by western blot. The samples are harvested from cells and mice. The results show that ISL could effectively decrease protein levels of p-IκB in HK2 of the LPS-induced mice but increase IκB-α.

    Isoliquiritigenin purchased from MedChemExpress. Usage Cited in: Am J Transl Res. 2018 Dec 15;10(12):4141-4151.  [Abstract]

    The expression of CD68, CD206, iNOS, MPO is determined by immunohistochemistry in four animal groups. LPS increases the expression of CD68, iNOS and MPO but decreases the expression of CD206 in murine kidney, while ISL reduces the expression of CD68, iNOS and MPO then increases the expression of CD206 in mice kidney after LPS injection.

    Isoliquiritigenin purchased from MedChemExpress. Usage Cited in: Open Life Sci. 2017; 12: 300–307

    Western blot assays detect apoptosis-related protein expression of Bax, Bcl-2, active caspase-3.
    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Isoliquiritigenin is an anti-tumor flavonoid from the root of Glycyrrhiza uralensis Fisch., which inhibits aldose reductase with an IC50 of 320 nM. Isoliquiritigenin is a potent inhibitor of influenza virus replication with an EC50 of 24.7 μM.

    IC50 & Target

    IC50: 320 nM (Aldose reductase)

    In Vitro

    Isoliquiritigenin may prevent diabetic complications through inhibiting rat lens aldose reductase with IC50=320 nM and sorbitol accumulation in human red blood cells with IC50=2.0 μM[1]. Isoliquiritigenin (100 μM) markedly inhibits the hypoxia-induced prolonged TPS and TR90 of cardiomyocytes. Isoliquiritigenin significantly triggers AMPK Thr172 phosphorylation as compared with vehicle group. Isoliquiritigenin treatment also induces extracellular signal-regulated kinase (ERK) signaling pathway in the cardiomyocytes. Isoliquiritigenin treatment significantly decreases the intracellular ROS levels of isolated cardiomyocytes during hypoxia/reoxygenation[3]. Isoliquiritigenin not only downregulates IL-6 expression but also significantly decreases levels of phosphorylated ERK and STAT3 and can inhibit phosphorylation levels of ERK and STAT3 induced by recombinant human IL-6, which are critical signaling proteins in IL-6 signaling regulation networks[4].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    In Vivo

    Isoliquiritigenin shows concentration-dependent inhibition of the tonic contraction of mouse jejunum induced by various types of stimulants such as CCh (1 mM), KCl (60 mM) and BaCl2 (0.3 mM) with IC50 values of 4.96±1.97 mM, 4.03±1.34 mM and 3.70±0.58 mM, respectively[2]. Isoliquiritigenin exhibits significant anti-tumor activity in MM xenograft models and synergistically enhances the anti-myeloma activity of adriamycin[4].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Molecular Weight

    256.25

    Formula

    C15H12O4

    CAS No.
    Appearance

    Solid

    Color

    Light yellow to yellow

    SMILES

    O=C(C1=CC=C(O)C=C1O)/C=C/C2=CC=C(O)C=C2

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 1 year
    -20°C 6 months
    Solvent & Solubility
    In Vitro: 

    Ethanol : 100 mg/mL (390.24 mM; Need ultrasonic)

    DMSO : ≥ 100 mg/mL (390.24 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    *"≥" means soluble, but saturation unknown.

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 3.9024 mL 19.5122 mL 39.0244 mL
    5 mM 0.7805 mL 3.9024 mL 7.8049 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 years; -20°C, 6 months. When stored at -80°C, please use it within 1 years. When stored at -20°C, please use it within 6 months.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.5 mg/mL (9.76 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.5 mg/mL (9.76 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation
    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 years; -20°C, 6 months. When stored at -80°C, please use it within 1 years. When stored at -20°C, please use it within 6 months.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    Ethanol / DMSO 1 mM 3.9024 mL 19.5122 mL 39.0244 mL 97.5610 mL
    5 mM 0.7805 mL 3.9024 mL 7.8049 mL 19.5122 mL
    10 mM 0.3902 mL 1.9512 mL 3.9024 mL 9.7561 mL
    15 mM 0.2602 mL 1.3008 mL 2.6016 mL 6.5041 mL
    20 mM 0.1951 mL 0.9756 mL 1.9512 mL 4.8780 mL
    25 mM 0.1561 mL 0.7805 mL 1.5610 mL 3.9024 mL
    30 mM 0.1301 mL 0.6504 mL 1.3008 mL 3.2520 mL
    40 mM 0.0976 mL 0.4878 mL 0.9756 mL 2.4390 mL
    50 mM 0.0780 mL 0.3902 mL 0.7805 mL 1.9512 mL
    60 mM 0.0650 mL 0.3252 mL 0.6504 mL 1.6260 mL
    80 mM 0.0488 mL 0.2439 mL 0.4878 mL 1.2195 mL
    100 mM 0.0390 mL 0.1951 mL 0.3902 mL 0.9756 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Salutation

    Applicant Name *

     

    Email Address *

    Phone Number *

     

    Organization Name *

    Department *

     

    Requested quantity *

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Isoliquiritigenin
    Cat. No.:
    HY-N0102
    Quantity:
    MCE Japan Authorized Agent: